Amryt Pharma - New Distribution Agreement Signed Completing Lojuxta Footprint in Eastern Europe - Raglan Capital

Home
About Us
Selected Transactions
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Amryt Pharma – New Distribution Agreement Signed Completing Lojuxta Footprint in Eastern Europe

Home
2018
Amryt Pharma – New Distribution Agreement Signed Completing Lojuxta Footprint in Eastern Europe

Recent News

World’s first trial of deliberate coronavirus infection is approved
Scientists win approval to infect healthy volunteers with Covid for trial
Open Orphan gets final go-ahead for Covid-19 human trial
Covid-19: World’s first human challenge trials to start in UK
COVID-19: Volunteers to be exposed to virus in world-first study in UK
Open Orphan starts trials on nasal spray COVID-19 vaccines

Amryt Pharma - New Distribution Agreement Signed Completing Lojuxta Footprint in Eastern Europe

30 January 2018

https://otp.investis.com/clients/uk/amryt_pharmaceuticals_dac1/rns/regulatory-story.aspx?cid=1375&newsid=971834

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2021 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences